Byetta - TuDiabetes
Links shared publicly online about this topic.
- 32total visits
Byetta - TuDiabetes
View full resource at tudiabetes.org
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Byetta
Most Recently Shared on August 31, 2011 at 8:28 pm By:
Type2 #diabetes: Byetta - I have been prescribed Byetta...today, it is kicking me left and right. I feel totally ful... http://t.co/4iM93jQ
Byetta cleared for add-on therapy with basal insulin in EU | BioPortfolio.com
bioportfolio.com — “From BioPortfolio: US biotech firm Amylin Pharmaceuticals (Nasdaq: AMLN) and drug major Eli Lilly (NYSE: LLY) said on Friday that the European Commission has granted marketing aut...” View full resource at bioportfolio.com
Most Recently Shared on March 26, 2012 at 9:37 am By:
BioPortfolio News Byetta cleared for addon therapy with basal insulin in EU: US biotech firm A... http://t.co/JKCjSA5t BioPortfolio News
Eli Lilly and Company - BYETTA® Approved for Use with Basal Insulin in Europe
newsroom.lilly.com — “Eli Lilly and Company - BYETTA® Approved for Use with Basal Insulin in Europe” View full resource at newsroom.lilly.com
Most Recently Shared on March 23, 2012 at 6:43 pm By:
BYETTA® Approved for Use with Basal Insulin in Europe (Lilly) http://t.co/W8GNvepK
Amylin: EU Approves Diabetes Treatment Byetta With Basal Insulin | Fox Business
foxbusiness.com — “DOW JONES NEWSWIRES” View full resource at foxbusiness.com
Most Recently Shared on March 23, 2012 at 5:07 pm By:
Ann Bartlett Therapist and ePatient
RT @shelleypetersen: Amylin: EU approves #diabetes treatment Byetta with basal insulin http://t.co/COuthHf7 #healthinnovations #pharma...
BYETTA® Approved for Use with Basal Insulin in Europe -- SAN DIEGO and INDIANAPOLIS, March 23, 2012 /PRNewswire/ --
prnewswire.com — “BYETTA® Approved for Use with Basal Insulin in Europe. Patients in Pivotal Study Achieved Better Glycemic Control Overall and After Meals.” View full resource at prnewswire.com
Most Recently Shared on March 23, 2012 at 2:41 pm By:
Scott Strumello Patient Expert
Byetta Approved for Use with Basal Insulin in Europe http://t.co/qV6xoa2T via @PRNewswire
European Commission grants marketing authorization for use of BYETTA with basal insulin
news-medical.net — “Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced today that the European Commission has granted marketing authorization to BYETTA (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos (pioglitazone), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.” View full resource at news-medical.net
Most Recently Shared on March 23, 2012 at 1:57 pm By:
European Commission grants marketing authorization for use of BYETTA with basal insulin: Amylin Pharmaceuticals,... http://t.co/3EqmxLdM
Amylin Pharmaceuticals ª Investors ª RSS Content
investors.amylin.com — “Amylin Pharmaceuticals” View full resource at investors.amylin.com
Most Recently Shared on March 23, 2012 at 1:25 pm By:
eyeonfda Pharma and Health Lawyer
BYETTA® Approved for Use with Basal Insulin in Europe http://t.co/39aOOqpA #diabetes
Comments of using Cycloset, Crestor, Actos, Metformin Hydrochloride, Byetta, Lisinopril (study 6037098) - eHealthMe.com
ehealthme.com — “going to see a GI doctor based on recent elevated liver enzymes” View full resource at ehealthme.com
Most Recently Shared on March 13, 2012 at 9:21 pm By:
going to see a GI doctor based on recent elevated liver enzymes http://t.co/NFfxSF5Y
Bydureon Approved for Type 2 Diabetes - Drugs.com MedNews
drugs.com — “Bydureon (exenatide extended release), Amylin Pharmaceuticals long-acting version of the diabetes drug Byetta, has been approved by the U.S. Food and Drug Admin” View full resource at drugs.com
Most Recently Shared on January 28, 2012 at 3:17 am By:
Bydureon Approved for Type 2 Diabetes - http://t.co/qjuW2b7N
U.S. FDA approves Amylin's diabetes drug - Yahoo! News
news.yahoo.com — “From Yahoo! News: WASHINGTON (Reuters) - Amylin Pharmaceuticals Inc won U.S. approval on Friday for its Bydureon diabetes drug, a long-awaited victory for the company's most promising product. After two delays, the Food and Drug Administration approved once-weekly injectable Bydureon for treating adults with Type 2 diabetes, which is linked to poor diet and lack of exercise. Bydureon is a longer-acting form of Amylin's older Byetta treatment. Amylin shares jumped 16.6 percent to $14.16 in after ” View full resource at news.yahoo.com
Most Recently Shared on January 27, 2012 at 11:26 pm By:
U.S. FDA approves Amylin's diabetes drug: WASHINGTON (Reuters) - Amylin Pharmaceuticals Inc won U.S. approval on... http://t.co/5R3g6RBT
Amylin's long-delayed diabetes drug gets FDA nod - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: Amylin Pharmaceuticals won approval Friday for its long-delayed diabetes drug Bydureon, a next-generation treatment that requires fewer injections than the company's 7-year old diabetes medicine, Byetta.Bydureon ...” View full resource at finance.yahoo.com
Most Recently Shared on January 27, 2012 at 11:26 pm By:
Amylin's long-delayed diabetes drug gets FDA nod: Amylin Pharmaceuticals won approval Friday for its long-delaye... http://t.co/JwfZEtSA
Bydureon Approved for Type 2 Diabetes - Yahoo! News
news.yahoo.com — “From Yahoo! News: FRIDAY, Jan. 27 (HealthDay News) -- Bydureon (exenatide extended release), Amylin Pharmaceuticals' long-acting version of the diabetes drug Byetta, has been approved by the U.S. Food and Drug Administration.” View full resource at news.yahoo.com
Most Recently Shared on January 27, 2012 at 11:26 pm By:
Bydureon Approved for Type 2 Diabetes: FRIDAY, Jan. 27 (HealthDay News) -- Bydureon (exenatide extended release)... http://t.co/OSWGzmKz
Diabetes drug may be effective for weight-loss - QualityPoint Technologies
qualitypointtech.net — “Medicines such as Byetta may help users shed pounds, but more study is needed, experts say. (Source: USATODAY.com Health)” View full resource at qualitypointtech.net
Most Recently Shared on January 15, 2012 at 11:45 pm By:
Diabetes drug may be effective for weight-loss: Medicines such as Byetta may help users shed pounds, but more stud... http://t.co/sLLRrs8E
Certain Diabetes Drugs Might Aid Weight Loss - Yahoo! News
news.yahoo.com — “From Yahoo! News: TUESDAY, Jan. 10 (HealthDay News) -- A class of newer diabetes drugs that includes exenatide (Byetta, Bydureon) might also be used to help the obese lose weight, Danish researchers report.” View full resource at news.yahoo.com
Most Recently Shared on January 13, 2012 at 9:58 pm By:
Certain #Diabetes Drugs Might Aid Weight Loss - Yahoo! News http://t.co/36Sw88N7
Byetta Fights Inflammation, Study Shows :: Diabetes Self-Management
diabetesselfmanagement.com — “The injectable Type 2 diabetes drug Byetta has a strong and rapid anti-inflammatory effect, according to new research from the University of Buffalo....” View full resource at diabetesselfmanagement.com
Most Recently Shared on November 18, 2011 at 8:24 pm By:
Diabetes Self-Mgmt Health Site
#diabetes Byetta fights inflammation, study shows. http://t.co/jfBJay1g
Lilly And Amylin End Their Bad Marriage - Forbes
forbes.com — “Six months after a bitter dispute led to an unusual court battle, Eli Lilly and Amylin Pharmaceuticals are getting divorced. The two drugmakers announced they are ending their venture to develop and market diabetes meds, and Amylin will take control of the twice-a-day Byetta drug, as well as Bydureon, a once-weekly injectable that is designed to supplant the older drug.” View full resource at forbes.com
Most Recently Shared on November 8, 2011 at 8:38 pm By:
Scott Strumello Patient Expert
Lilly And Amylin End Their Bad Marriage - Forbes http://t.co/UaYtpxzZ
Advertisement
